trending Market Intelligence /marketintelligence/en/news-insights/trending/t2JyR0end5aTpwGNwTkXHA2 content esgSubNav
In This List

China SXT Pharmaceuticals closes IPO

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


China SXT Pharmaceuticals closes IPO

China SXT Pharmaceuticals Inc. closed its IPO, issuing 2,546,275 common shares priced at $4 each.

The China-based company, which develops, manufactures and sells traditional Chinese medicine pieces, known as TCMP, raised gross proceeds of $10.2 million.

The company plans to use the net proceeds to expand its manufacturing facility and employee base and for funding development and research of new drugs. According to China SXT, the amount raised will also be used as general working capital.

The shares sold under the IPO will start trading Jan. 4 on the Nasdaq Capital Market under the symbol SXTC.

Boustead Securities LLC acted as the sole underwriter for the offering. Hunter Taubman Fischer & Li LLC acted as legal counsel.